Target intelligence / Profile preview

Staphylococcal surface protein (MSCRAMM)

Target
MSCRAMM
Molecular classification
Receptor, Other
01

Overview

Staphylococcal surface receptors, primarily belonging to the Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) family, are essential virulence factors anchored to the cell wall of Staphylococcus aureus (Foster et al., 2014). These receptors, which include Protein A (Spa), Clumping factor A (ClfA), and Fibronectin-binding proteins (FnbpA/B), mediate the critical first step of infection by adhering to host extracellular matrix proteins like fibrinogen, collagen, and fibronectin (Speziale et al., 2009). Beyond simple attachment, these proteins facilitate immune evasion; for example, Protein A binds the Fc region of host antibodies to prevent opsonization and subsequent phagocytosis (Foster et al., 2014). Due to their surface exposure and vital roles in pathogenesis, they are primary targets for the development of passive and active immunotherapies, such as the monoclonal antibody Tefibazumab and the IsdB-targeting vaccine V710 (PubMed, 2023). However, the high degree of functional redundancy and genetic diversity among these surface receptors across different clinical isolates remains a major hurdle for achieving broad therapeutic efficacy (Nature Reviews Microbiology, 2014).

Other names
Microbial surface components recognizing adhesive matrix moleculesMSCRAMMsStaphylococcus aureus adhesinsCell wall-anchored proteinsS. aureus surface proteins
02

Mechanism of action

Inhibition of bacterial adhesion to host tissues, neutralization of immune evasion mechanisms, and promotion of opsonophagocytic clearance by the host immune system.

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Functional redundancy among surface proteins leading to therapeutic escapeHigh antigenic variation between S. aureus strainsPotential for cross-reactivity with host proteinsRisk of immune complex-mediated hypersensitivity
06

Interacting drugs

Tefibazumab

3 more in the full profile.

07

Biomarkers

Anti-ClfA antibody titersAnti-Spa antibody levelsStaphylococcus aureus colonization density

Beyond the preview

Go deeper on Staphylococcal surface protein (MSCRAMM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcal surface protein (MSCRAMM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call